| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025454338 |
| P356 | DOI | 10.1038/BJC.1996.583 |
| P932 | PMC publication ID | 2074868 |
| P698 | PubMed publication ID | 8932329 |
| P5875 | ResearchGate publication ID | 14275501 |
| P2093 | author name string | M Russell | |
| D J Brooks | |||
| S Woodward | |||
| D S Alberts | |||
| J Trent | |||
| J M Yang | |||
| X Y Guan | |||
| B Dos Santos | |||
| R Taetle | |||
| F H Thompson | |||
| P2860 | cites work | AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas | Q24294176 |
| Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26 | Q24561670 | ||
| Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
| Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts | Q28300889 | ||
| Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene | Q28593209 | ||
| Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. | Q33680461 | ||
| The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations | Q33749095 | ||
| Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene | Q36413795 | ||
| ras oncogene activation in human ovarian carcinoma | Q36445310 | ||
| Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias | Q36550719 | ||
| Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA. | Q36690799 | ||
| Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein | Q36692472 | ||
| Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors | Q36780634 | ||
| Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells | Q36992118 | ||
| Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain. | Q38304186 | ||
| Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations | Q38305391 | ||
| Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells. | Q38310692 | ||
| DNA binding by proteins | Q39253593 | ||
| The use of avidin-biotin interaction in immunoenzymatic techniques | Q39563816 | ||
| Transition metals in control of gene expression | Q40830496 | ||
| Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line. | Q41410542 | ||
| Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1 | Q41625385 | ||
| Transcriptional repression mediated by the WT1 Wilms tumor gene product | Q41661461 | ||
| Modulation ofcis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells | Q41673804 | ||
| Analysis of granulocyte-macrophage colony-stimulating factor action in differentiating myeloid leukemia cells: treatment with DMSO may reveal a common pathway for growth factor gene regulation | Q41692501 | ||
| Characterization of a factor-dependent acute leukemia cell line with translocation (3;3)(q21;q26) | Q41720935 | ||
| The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes | Q41724152 | ||
| Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells | Q41947149 | ||
| Comparison of four new cell lines from patients with adenocarcinoma of the ovary | Q42801481 | ||
| EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC. | Q42827546 | ||
| Cancer statistics, 1994. | Q43560974 | ||
| Phosphoinositide metabolism in human prostate cancer cells in vitro | Q44063536 | ||
| Use of nude mouse xenografts as preclinical screens. Characterization of xenograft-derived melanoma cell lines. | Q46014158 | ||
| Migrations of the Caenorhabditis elegans HSNs are regulated by egl-43, a gene encoding two zinc finger proteins | Q46532458 | ||
| Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion. | Q50592279 | ||
| Comparative properties of five human ovarian adenocarcinoma cell lines. | Q52828489 | ||
| p53 mutation is a common genetic event in ovarian carcinoma. | Q53389916 | ||
| Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. | Q53462356 | ||
| Amplification of 19q13.1–q13.2 sequences in ovarian cancer | Q58321636 | ||
| Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development | Q67975653 | ||
| Protooncogene amplification and tumor ploidy in human ovarian neoplasms | Q68085150 | ||
| Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas | Q69769033 | ||
| Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells | Q69782297 | ||
| Overexpression and mutation of p53 in epithelial ovarian cancer | Q70154017 | ||
| Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis | Q70510929 | ||
| Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice | Q71222723 | ||
| Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer: a multivariate analysis | Q72208402 | ||
| Clonal chromosome abnormalities in 54 cases of ovarian carcinoma | Q72399678 | ||
| Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer | Q72669074 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1518-1525 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Expression of the zinc finger gene EVI-1 in ovarian and other cancers | |
| P478 | volume | 74 |
| Q39751557 | A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer |
| Q35777532 | Analysis of molecular aberrations in ovarian cancer allows novel target identification |
| Q33769741 | Arsenic trioxide induces apoptosis in the THP1 cell line by downregulating EVI-1 |
| Q73270686 | Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases |
| Q36747434 | Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis |
| Q63379240 | Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex |
| Q89666667 | Downregulation of EVI1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Hilar Cholangiocarcinoma via the PTEN/AKT Signalling Pathway |
| Q37068625 | EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation |
| Q35904233 | EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma |
| Q47552808 | Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells |
| Q39401617 | Ecotropic viral integration site 1, a novel oncogene in prostate cancer |
| Q92684145 | Ecotropic virus integration-1 and calreticulin as novel prognostic markers in triple-negative breast cancer: A retrospective cohort study |
| Q57570317 | Epigenetic Mechanisms in Cancer Formation and Progression |
| Q26744080 | Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies |
| Q28296029 | Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT |
| Q45010451 | Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines |
| Q38459749 | Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity |
| Q39399124 | Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability |
| Q35107227 | Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects |
| Q36697860 | Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer |
| Q33427657 | Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia |
| Q30525568 | Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase. |
| Q37580699 | Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer |
| Q61795798 | PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma |
| Q33511042 | Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas |
| Q42751372 | Redundant roles of PRDM family members in zebrafish craniofacial development |
| Q28266315 | The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy |
| Q41930387 | The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid |
| Q33939478 | The oncoprotein EVI1 and the DNA methyltransferase Dnmt3 co-operate in binding and de novo methylation of target DNA. |
| Q40109569 | Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes |
| Q24793265 | Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer |
| Q39785476 | Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response. |
Search more.